Drug-induced lung disease

Cleveland Clinic Journal of Medicine

Volumn 68, Issue 9, 2001, Pages 782-795

  Özkan, Metin ^a   Dweik, Raed A ^a   Ahmad, Muzaffar ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Dept Pulmon and Critical Care Med ^*

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMINOSALICYLIC ACID; AMIODARONE; AMPICILLIN; ANOREXIGENIC AGENT; ANTIDEPRESSANT AGENT; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; BLEOMYCIN; BROMOCRIPTINE; BUSULFAN; CARDIOVASCULAR AGENT; CARMUSTINE; CEPHALOSPORIN DERIVATIVE; CYCLOPHOSPHAMIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERGOTAMINE; ETHAMBUTOL; HYDROCHLOROTHIAZIDE; IMMUNOSUPPRESSIVE AGENT; ISOXSUPRINE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LOMUSTINE; MELPHALAN; METHOTREXATE; MINOCYCLINE; MITOMYCIN C; NEUROLEPTIC AGENT; NITROFURANTOIN; NONSTEROID ANTIINFLAMMATORY AGENT; PACLITAXEL; PENTAMIDINE; PROCARBAZINE; RITODRINE; SALAZOSULFAPYRIDINE; SEMUSTINE; TERBUTALINE; TETRACYCLINE; UNINDEXED DRUG; ZAFIRLUKAST;

BRONCHOSPASM; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; FIBROSING ALVEOLITIS; HUMAN; INTERSTITIAL PNEUMONIA; LUNG DISEASE; LUNG EDEMA; LUPUS ERYTHEMATOSUS; PLEURA EFFUSION; PNEUMOTHORAX; PULMONARY HYPERTENSION; REVIEW;

EID: 0034852882     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.68.9.782     Document Type: Review

References (28)

1. Rosenow EC. The spectrum of drug-induced pulmonary disease. Ann Intern Med 1972; 77:977-991.
2. Pulmonary disease caused by toxins, drugs, and irradiation. In: Fraser RS, Müller NL, Colman N, Pare PD, editors. Diagnosis of diseases of the chest Philadelphia: W.B. Saunders, 1999:2517-2592.
3. Rosenow EC. Drug-induced pulmonary disease. Dis Mon 1994; 40:253-310.
4. Dweik RA, Ahmad M. Drug-induced pulmonary disease. In: Baum GL, Celli JDC, Karlinsky JB, editors. Textbook of pulmonary diseases, 6th ed Philadelphia: Lippincott-Raven Publishers, 1998:477-490.
5. Miller WT. Pleural and mediastinal disorders related to drug use. Semin Roentgenol 1995; 30:35-48.
6. Rich S, Rubin L, Walker AM, Schneeweiss S, Abenhaim L. Anorexigens and pulmonary hypertension in the United States: results from the surveillance of the North American pulmonary hypertension. Chest 2000; 117:870-874.
7. Schur PH, Rose BD. Drug-induced lupus UpToDate in pulmonary and critical care medicine [on CD-ROM] American Thoracic Society; v.8.1, 2000.
8. Meeker DP, Wiedemann HP. Drug-induced bronchospasm. Clin Chest Med 1990; 11:163-175.
9. Copper JAD Jr. Drug-induced lung disease. Adv Intern Med 1997; 42:231-268.
10. Chan ED, King TE. Amiodarone pulmonary toxicity. UpToDate in pulmonary and critical care medicine [on CD-ROM]. American Thoracic Society; v.8.1, 2000.
11. Israili ZH, Hall WD. Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology. Ann Intern Med 1992; 117:234-242.
12. Malini PL, Strocchi E, Zanardi M, et al. Thromboxane antagonism and cough induced by angiotensin-converting-enzyme inhibitor. Lancet 1997; 350:15-18.
13. Chan ED, King TE. Mitomycin-C pulmonary toxicity UpToDate in pulmonary and critical care medicine [on CD-ROM]. American Thoracic Society; v.8.1, 2000
14. Russi EW. Busulfan-induced pulmonary injury. UpToDate in pulmonary and critical care medicine [on CD-ROM]. American Thoracic Society; v.8 1, 2000.
15. O'Driscoll R. Nitrosourea (carmustine)-induced pulmonary injury. UpToDate in Pulmonary and Critical Care Medicine [on CD-ROM]. American Thoracic Society; v.8 1, 2000.
16. Goldberg HL, Vannice SB. Pneumonitis related to treatment with paclitaxel. J Clin Oncol 1995; 13:534-535.
17. De Zeeuw J, Schumacher J, Werninghous GS, Gillishen AG. Nitrofurantoin-induced pulmonary injury. UpToDate in pulmonary and critical care medicine [on CD-ROM] American Thoracic Society; v.8.1, 2000.
18. Cameron RJ, Kolbe J, Wilsher ML, Lambie N. Bronchiolitis obliterans organizing pneumonia associated with the use of nitrofurantoin. Thorax 2000; 55:249-251.
19. Christodoulou CS, Emmanuel P, Ray RA, Good RA, Schnapf BM, Cawkwell GD. Respiratory distress due to minocycline-induced pulmonary lupus. Chest 1999; 115:1471-1473.
20. Voelkel NF. Appetite suppressants and pulmonary hypertension. Thorax 1997; 52:563-567.
21. Abenhaim L, Moride Y, Brenot F, et al. Appetite-suppressant drugs and the risk of pulmonary hypertension. N Engl J Med 1996, 335:609-616.
22. Herve P, Launay JM, Scrobohaci ML, et al. Increased plasma serotonin in primary pulmonary hypertension. Am J Med 1995; 99:249-254.
23. Lee SL, Wang WW, Lanzillo JJ, Fanburg BL. Serotonin produces both hyperplasia and hypertrophy of bovine pulmonary artery smooth muscle cells in culture. Am J Physiol 1994; 266:L46-L52.
24. Archer SL, Djaballah K, Humbert M, et al. Nitric oxide deficiency in fenfluramine- and dexfenfluramine-induced pulmonary hypertension. Am J Respir Crit Care Med 1998; 158:1061-1067.
25. Pisani RJ, Rosenow III EC. Pulmonary edema associated with tocolytic therapy. Ann Intern Med 1989; 110:714-718
26. Wechsler ME, Garpestad E, Flier SR, et al. Pulmonary infiltrates, eosinophilia, and cardiomyopathy following corticosteroid withdrawal in patients with asthma receiving zafirlukast. JAMA 1998; 279:455-457.
27. Gearhart MO, Bhutani MS. Intravenous pentamidine-induced bronchospasm. Chest 1992; 102:1891-1892.
28. Katzman M, Meada W, lglar K, Rachlis A, Berger P, Chan CK. High incidence of bronchospasm with regular administration of aerosolized pentamidine. Chest 1992; 101:79-81